Click Here to
News, Updates,
& More
Stay Up
to Date

JHOP - June 2018 Vol 8, No 2

Ákos Juhász, PharmD, and colleagues suggest that the use of a closed-system drug-transfer device would reduce the high levels of contamination found in hospital pharmacies.

In their study, Mark L. Zangardi, PharmD, BCOP, and colleagues, demonstrate that clinical pharmacists have an integral role in the review and approval of off-label oncology treatments.

This pilot study demonstrated that pharmacists in an ambulatory oncology clinic are able to deliver successful tobacco-cessation counseling and interventions for patients with cancer who smoke.

  • How Oncology Pharmacists Can Enhance Patient Quality of Care
  • Metastasis-Free Survival for Prostate Cancer Longerwith Apalutamide than with Placebo
  • Nivolumab plus Ipilimumab Combination Improves Overall Survival in Untreated Renal-Cell Carcinoma

Results 1 - 4 of 4